Ramper's Dictionary22 Apr 2020 08:49
'The right thing to do is move on.'
This means that if you have been disappointed by this share please do not let potential investors know of any problems that you believe could harm their potential investment. In Valirx's case it could be considered unwelcome to mention the numerous consolidations, the fact that shareholders got together to force the resignation of senior Directors, death-spiral placings / loan agreements, insignificant trial data, delays etc. Others may be prepared to add to the list of perceived problems.
Unfortunately for the Rampers we are in a Covid-2019 lockdown - previous shareholders now have too much time on their hands. Maybe one of the new positive posters can provide a scientific and business argument on why Valirx is now an investment case other than the potential cash-shell value?